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Purpose: If cholesterol in the cell membrane is depleted by treating cells with 
methyl-β-cyclodextrin (MβCD), the activities of transmembrane receptors are al-
tered in a cell-specific and/or receptor-specific manner. The proinflammatory cyto-
kines, IL-1β is potent inducers of MUC5AC mRNA and protein synthesis in human 
airway epithelial cells. Cells activated by IL-1β showed increased phosphorylation 
of extracellular signal regulated kinase (ERK) and p38 mitogen-activated protein 
kinase (MAPK). Thus, we investigated the effects of cholesterol depletion on the 
expression of MUC5AC in human airway epithelial cells and whether these altera-
tions to MUC5AC expression were related to MAPK activity. Materials and 
Methods: After NCI-H292 cells were pretreated with 1% MβCD before adding 
IL-1β for 24 hours, MUC5AC mRNA expression was determined by reverse tran-
scription-polymerase chain reaction (RT-PCR) and real time-PCR. Cholesterol de-
pletion by MβCD was measured by modified microenzymatic fluorescence assay 
and filipin staining. The phosphorylation of IL-1 receptor, ERK and p38 MAPK, 
was analyzed by western blot. Results: Cholesterol in the cell membrane was sig-
nificantly depleted by treatment with MβCD on cells. IL-1β-induced MUC5AC 
mRNA expression was decreased by MβCD and this decrease occurred IL-1-re-
ceptor-specifically. Moreover, we have shown that MβCD suppressed the activa-
tion of ERK1/2 and p38 MAPK in cells activated with IL-1β. This result suggests 
that MβCD-mediated suppression of IL-1β-induced MUC5AC mRNA operated 
via the ERK- and p38 MAPK-dependent pathway. Conclusion: Cholesterol deple-
tion in NCI-H292 cell membrane may be considered an anti-hypersecretory meth-
od since it effectively inhibits mucus secretion of respiratory epithelial cells.
Key Words:   Cholesterol, cell membrane, cultured cells, mucins, MAP kinases
INTRODUCTION
Cholesterol is an essential component of the plasma membranes of eukaryotic 
cells and plays important roles in membrane fluidity, permeability, receptor func-
tion, and ion channel activity.1-4 The concentration of cholesterol is focally high in 
the submicroscopic areas enriched with sphingolipids and gangliosides. These mi-
crodomains, known as lipid rafts, are associated with the regulation of transmem-
brane receptors, especially tyrosine kinase receptors and G protein-coupled recep-
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tems, Minneapolis, MN, USA) treatment. Some cultures 
were pretreated with MβCD (Sigma Chemical Co., St. Lou-
is, MO, USA) for 1 hour before being exposed to IL-1β. IL-
1β was dissolved with PBS containing 0.1% bovine serum 
albumin.
Materials
MβCD was purchased from Sigma Chemical Co.; IL-1β 
was purchased from R&D Systems; anti-phospho-Type I 
IL-1 receptor (phospho-Y496) antibody (IL-1RI) was pur-
chased from Abcam Co. (Cambridge, MA, USA); anti-
phospho-p44/42 MAPK (Thr202/Tyr204) antibodies and anti-
phospho-p38 MAPK (Thr180/Tyr182) antibodies, were purch-
ased from Cell Signaling Co. (Beverly, MA, USA).
Determination of cell viability (MTS assay)
Cell viability was determined by MTS [3-(4,5-dimethylthi-
azol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, inner salt] and electron coupling reagent 
(phenazine ethosulfate) assays. The cells were seeded on 96 
well plates at 2000 cells/well. After serum starvation for 24 
hours, cells were then treated MβCD with at various con-
centrations (0, 0.5, 1, 2%) for 1 hour. After the exposure pe-
riod, the media were removed. Thereafter, the medium was 
changed and incubated with reagent (CellTiter96 AQueous 
One Solution Proliferation Assay: Promega, Madison, WI, 
USA) for 1 hour at 37°C, 5% CO2. Optical density was 
measured by spectrophotometer at 492 nm.
Measurement of intra-membranous cholesterol
Cells were rinsed twice with 1 mL cold PBS, and lipids 
were extracted with chloroform-methanol 2 : 1 (v/v). Ho-
mogenized cell lysates were centrifuged for 10 min at 
14000 rpm. The organic phase was transferred to a clean 
tube, dried under vacuum, and re-dissolved in 20 μL 2-pro-
panol and 10% Triton X-100. One μL per assay was used, 
and it was adjusted to 50 μL with cholesterol reaction buf-
fer in the wells of a 96-well plate. Cholesterol levels were 
measured using a modified microenzymatic fluorescence 
assay (Cayman Chemical Company, Ann Arbor, MI, USA) 
according to the manufacturer’s protocol. Samples were in-
cubated at 37°C for one hour. A spectrofluorometer (excita-
tion 544 nm and emission 590 nm) was used for measure-
ment. The protein concentrations of the supernatant were 
measured by bicinchronic acid protein assay using bovine 
serum albumin. The results were described as the ratio of 
cholesterol/cell protein (μg/mg).
tors. If cholesterol in lipid rafts is depleted by treating cells 
with methyl-β-cyclodextrin (MβCD), the activities of re-
ceptors are altered in a cell-specific and/or receptor-specific 
manner.5,6 
Mucin hypersecretion results in inflammatory airway dis-
eases such as rhinitis, sinusitis, and bronchitis. Various genes 
and cytokines are related to mucin secretion. Among hu-
man mucin genes, MUC5AC is recognized as the major air-
way mucin gene in the airway epithelium.7-9 Recently, it has 
been determined that IL-1β, a well-known proinflammatory 
cytokine, induces MUC5AC gene over-expression in NCI-
H292 cells via extracellular signal regulated kinase (ERK)/
p38 mitogen-activated protein kinase (MAPK) cascade.10,11 
As MAPK signal transduction is associated with regulation 
of MUC5AC, it has been postulated that cholesterol deple-
tion can influence MUC5AC gene expression in NCI-H292 
cells by changing the activity of MAPK. Other studies dem-
onstrated that MAPK activation was regulated by MβCD 
treatment in keratinocyte, NIH3T3 cells, and cultured hu-
man dermal fibroblasts.12-14 However, the relationship be-
tween MAPK and MUC5AC in human airway epithelial 
cells is still unknown. Therefore, we sought to investigate 
the effects of cholesterol depletion on the expression of 
MUC5AC in NCI-H292 cells. If the expression of MU-
C5AC is related to cholesterol depletion in the cell membrane 
of airway epithelial cells, we also sought to investigate 
whether the alteration of MUC5AC expression is related to 
MAPK activity. 
MATERIALS AND METHODS
　　　
Cell culture
Human pulmonary mucoepidermoid carcinoma cell lines 
(NCI-H292 cells) from American Type Culture Collection 
(Rockville, MD, USA) were cultured respectively in RPMI 
1640 (Gibco BRL, Grand Island, NY, USA) and DMEM 
(Gibco BRL, Grand Island, NY, USA) supplemented with 
10% fetal bovine serum (Cellgro, Hemdon, VA, USA) in 
the presence of 2 mM L-glutamine, penicillin (100 μg/mL) 
and streptomycin (100 μg/mL) at 37°C in a humidified 
chamber with 95% air and 5% CO2. When cultures reached 
60-80% confluence, the cells were incubated in each medi-
um containing 0.5% fetal bovine serum for 24 hours, after 
which they were rinsed with phosphate buffered saline 
(PBS) and exposed to the indicated concentrations of re-
agents sub-sequent human recombinant IL-1β (R&D Sys-
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sured via bicinchronic acid protein assay and bovine serum 
albumin was also added. Next, the protein was placed into 
lanes by 30 μg and electrophoresis was performed. We re-
spectively used 4-12% gel (Invitrogen, Grand Island, NY, 
USA) in IL-1RI analysis and 8% SDS-polyacrylamide gel 
in MAPK analysis for electrophoresis. Afterwards, they 
were transferred to the nitrocellulose membrane. We then 
performed Western blot analysis using a previously de-
scribed method.11 We used p-IL-1RI (1 : 500), p-ERK (1 : 
1000), and p-p38 MAPK (1 : 1000) antibodies.  
Statistics
The experiment was performed at least three times and the 
mean value and the standard deviation for all experiments 
were calculated. The repeated measures ANOVA test was 
used to analyze differences, and multiple comparisons were 
added. Cases in which the p-value was less than 0.05 were 
defined as significant.
 
RESULTS
 
Cell viability by cholesterol depletion of cell membranes 
in NCI-H292 cells  
We treated cells with MβCD at various concentrations (0, 
0.5%, 1%, 2%) for 1 hour, and examined cell viability. 0.5% 
MβCD showed 88±8% cell viability compared to the control 
group (no treatment with MβCD) and 1% MβCD showed 83 
±10% and 2% MβCD showed 60±5% (Fig. 1). Cells ex-
posed to 1% MβCD exhibited normal viability, but those 
exposed to 2% MβCD showed loss of cell viability. There-
Filipin staining
Cells, cultured in the polysin-coated cover slip, were divid-
ed into two groups; a control group and an experimental 
group, and treated with MβCD. Subsequently, cells were 
rinsed with cold PBS and fixed on ice using 4% parafor-
maldehyde. The cells were rinsed again with cold PBS for 
10 min, and stained at room temperature with 100 μg/mL 
of filipin (Sigma Chemical Co., St. Louis, MO, USA) for 2 
hours. After being rinsed once with PBS, the cells were ob-
served through a fluorescence microscope with a UV filter 
set (340-380 nm excitation, 40 diachronic, 430 nm long 
pass filter).
Reverse transcription-polymerase chain reaction 
(RT-PCR) analysis of MUC5AC mRNA 
The total RNA was isolated from cells under each condi-
tion using TRI-reagent (Molecular Research Center, Cin-
cinnati, OH, USA). Total RNA (1 μg/20 μL) was reverse 
transcribed into cDNA using random hexanucleotide prim-
ers and Moloney murine leukemia virus reverse transcrip-
tase (Gibco-BRL), and MUC5AC cDNA was amplified by 
PCR using a Perkin-Elmer Cetus DNA Thermal Cycler 
(Perkin-Elmer, Norwalk, CT, USA) using the previously 
described method.11 β2-microglobulin (β2M) was used as a 
control gene for RT-PCR. 
   
Real-time polymerase chain reaction of MUC5AC 
mRNA 
Primers and probes were designed using Applied Biosys-
tems Primer Express software and purchased from Applied 
Biosystems (Carlsbad, CA, USA). Commercial reagents 
(TaqMan Universal PCR Master Mix; Applied Biosystems) 
and conditions were applied in accordance with the manu-
facturer’s protocol. One μg of cDNA (reverse transcription 
mixture) and oligonucleotides with final concentrations of 
800 nM for primers and 200 nM for TaqMan hybridization 
probes were analyzed in a 25 µL volume using a previously 
described method.11 Relative quantities of MUC5AC mRNA 
were obtained using a comparative cycle threshold method 
and normalized using β2M as an endogenous control. Ex-
pression was reported as a ratio of MUC5AC intensity to 
β2M intensity.
Western blot analysis
Cell lysates were made into cultured cells using a radioim-
munoprecipitation assay buffer (1% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS). Protein quantities were mea-
Fig. 1. Cell viability by cholesterol depletion in cell membranes of NCI-H292 
cells. Cell viability was examined after treatment with various concentra-
tions of MβCD, and the data were compared to that of the control group 
(CTRL). Cell survival is maintained above 80% with 1% MβCD treatment. 
Data are presented as mean±SD of six replicates from three independent 
experiments. MβCD, methyl-β-cyclodextrin; SD, standard deviation.
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along the cell membrane. However, in the MβCD-treatment 
group, the intensity of fluorescence decreased significantly 
(Fig. 2B). 
Suppression of MUC5AC expression after treatment 
with MβCD
We evaluated whether MβCD suppressed IL-1β-induced 
MUC5AC gene expression using RT-PCR and real time-
PCR, as well as whether this suppression occurred IL-1-re-
ceptor-specifically. Cells were pretreated with 1% MβCD 
for 1 hour, after which the media was freshly changed and 
cells were incubated with IL-1β (10 ng/mL) for 24 hours. 
We then picked MUC5AC mRNA and examined its expres-
sion through RT-PCR and real-time PCR. The expression of 
p-IL-1RI was examined by Western analysis. We found that 
IL-1β induced the expression of MUC5AC, but this increase 
was significantly decreased by treatment with MβCD in RT-
fore, we used 1% MβCD in the following experiments.
Verification of cholesterol depletion by MβCD 
treatment
To verify whether intra-membranous cholesterol was deplet-
ed after 1 hour of treatment with 1% MβCD, intra-membra-
nous cholesterol level analysis and filipin staining were per-
formed. After treatment with 1% MβCD for 1 hour, the 
intra-membranous cholesterol/protein ratio was calculated 
and the data for the experimental group was compared to 
that of the control group, which had not been treated with 
MβCD. As a result, the relative ratio of intra-membrane 
cholesterol/protein was 0.17±0.07. This result indicates that 
MβCD significantly decreased the cholesterol level in the 
cell membranes (p<0.05) (Fig. 2A).
With regards to the filipin staining, in the control group, 
filipin was observed to adhere specifically to cholesterol 
Fig. 2. Determination of intra-membranous cholesterol level by a modified microenzymatic fluorescence assay (A) and filipin staining (B). (A) The intra-mem-
branous cholesterol level was determined using a modified microenzymatic fluorescence assay. The amount was expressed in cholesterol/protein ratio, and 
the data of the experimental group were compared with that of the control group (no treatment of MβCD). The cholesterol/protein ratio is significantly de-
creased by 1% MβCD treatment in NCI-H292 cells (p<0.05). Data are presented as mean±SD of three independent experiments. (B) Filipin staining in NCI-H292 
cells after treatment with MβCD. Filipin staining was done in cells after one-hour pre-treatment of 1% MβCD with a fluorescence microscope. Compared to 
the control group, the staining intensity along the cell membrane was significantly weaker. MβCD, methyl-β-cyclodextrin; SD, standard deviation.
Fig. 3. MUC5AC gene expression after treatment with MβCD. NCI-H292 cells were pretreated with 1% MβCD for 1 hour, after which the media was freshly 
changed and cells were incubated with IL-1β (10 ng/mL) for 24 hours. MUC5AC gene expression was examined by RT-PCR (A) and real time-PCR (B) analy-
sis. β2M served as the internal control. The expression of p-IL-1RI was examined by Western analysis (C). α-tubulin served as the internal control. IL-1β in-
duces expression of MUC5AC, but this increased expression is significantly decreased by MβCD treatment (IL-1β+MβCD) (p<0.05). Data are presented as 
mean±SD of three independent experiments. The expression of p-IL-1RI increased according to IL-1β treatment, but this increase was decreased by MβCD 
treatment (IL-1β+MβCD). Data are presented from three independent experiments. MβCD, methyl-β-cyclodextrin; RT-PCR, reverse transcription-polymerase 
chain reaction; IL, interleukin.
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MβCD depleted the cholesterol of the plasma membrane. 
However, cholesterol is distributed both intramembranous-
ly and intracellularly, and intra-membranous cholesterol 
level analysis examines the relative ratio of cholesterol/pro-
tein.1,20,21 Therefore, we determined whether the cholesterol 
of the cell membrane was depleted through filipin staining. 
By staining filipin that selectively combines with cholesterol, 
we verified that filipin on the membrane was further de-
creased in MβCD-treated cell lines as compared to the con-
trol group. From this result, we confirmed that MβCD selec-
tively depletes the cell membrane’s cholesterol.
Because MUC5AC expression is induced by IL-1β in 
NCI-H292 cells, we applied MβCD before IL-1β treatment.11 
According to our results, MUC5AC expression was signifi-
cantly decreased. Next, we wondered whether these results 
were induced by the disruption of a ligand-specific receptor 
such as IL-1 receptor or not. Therefore, we examined wheth-
er the phosphorylation of IL-1 receptor is induced by IL-1β 
and whether such activation of the ligand-specific receptor is 
decreased by MβCD. As a result, the expression of p-IL-1RI 
was increased by IL-1β treatment, but this increase was sig-
nificantly decreased by MβCD treatment. Thus, we dis-
cerned the suppression of MUC5AC expression by MβCD to 
be an IL-1 receptor-specific reaction.
In order to reveal the possible signal pathway by which 
MUC5AC is decreased by MβCD, we examined the MAPK 
cascade. In our previous study of NCI-H292 cells, IL-1β 
maximally induced activation of p-ERK and p-p38 in the 
20 min after treatment.11 Thus, our experiments were per-
formed 20 min after IL-1β treatment. We found ERK and 
PCR and real-time PCR analysis (control : MβCD : IL-1β : 
IL-1β+MβCD=1 : 0.9±0.2 : 5.3±0.8 : 0.8±0.3) (p<0.05) 
(Fig. 3A and B). The expression of p-IL-1RI increased ac-
cording to the IL-1β treatment, but MβCD treatment signifi-
cantly decreased the expression of p-IL-1RI (Fig. 3C). 
MAPK’s changes by MβCD treatment
To figure out whether the decrease in MUC5AC expression 
induced by MβCD treatment was dependent upon the de-
pression of MAPK activity, we pre-treated cells for 1 hour 
with 1% MβCD. Then the media was freshly changed and 
cells were incubated with IL-1β for 20 min. A no MβCD or 
IL-1β treatment group was used as a negative control group 
and only IL-1β was administered in the positive control 
group. After each experiment, protein was obtained and a 
Western blot analysis of p-ERK and p-p38 MAPK was per-
formed. Elevated expression of p-ERK in only IL-1β-treated 
cells decreased markedly in both IL-1β and MβCD-treated 
cells (Fig. 4A). Expression of p-p38 was also reduced to the 
negative control level in both IL-1β and MβCD-treated cells 
(Fig. 4B). 
DISCUSSION
MβCD is a compound that specifically combines with cho-
lesterol, deletes it, and then disrupts the lipid raft. Due to this 
effect, MβCD affects kinases of plasma membrane receptors 
and may cause alterations to cell proliferation.15,16 These 
facts mean that MβCD induces inhibition of cell prolifera-
tion according to cell type and concentration of MβCD. It is 
thus necessary to determine the appropriate concentration 
of MβCD. Our results regarding cell viability were above 
80% when using 1% MβCD; therefore, this concentration 
was considered safe for maintaining cell survival. Although 
we found the appropriate concentration of MβCD, we fixed 
the treatment time at one hour. In other studies, the duration 
of treatment was 1 or 2 hours and, after reviewing previous 
results, we fixed our duration as 1 hour.17-19 In the preceding 
experiments, we treated cells for 2 hours at a 1% concentra-
tion, but cell proliferation was remarkably inhibited (data 
not shown), and we decided to use one hour as the experi-
mental time.
Our next step was to verify whether cholesterol was de-
pleted by MβCD in NCI-H292 cells via intra-membranous 
cholesterol level analysis and filipin staining. Through the 
intra-membranous cholesterol analysis, we found that 
Fig. 4. Suppression of IL-1β-induced activation of ERK and p38 MAPK by 
treatment with MβCD. NCI-H292 cells were pretreated for 1 hour with 1% 
MβCD, after which the media was freshly changed, cells were treated for 
20 min with IL-1β, and Western blot analysis was performed. Expression 
of both p-ERK (A) and p-p38 MAPK (B) is increased by IL-1β treatment (IL-
1β), but this increased expression of both p-ERK and p-p38 MAPK is de-
creased to the control level by MβCD treatment (IL-1β+MβCD). Data are 
presented from three independent experiments. ERK, extracellular signal 
regulated kinase; MAPK, mitogen-activated protein kinase; MβCD, methyl-
β-cyclodextrin; IL, interleukin.
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effectively inhibit mucus secretion in human airway epithe-
lial cells. 
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